If a state Medicaid plan denies the request, what recourse does the article describe
The FDA has not indicated plans to reclassify these drugs as over-the-counter in the foreseeable future, citing the importance of professional monitoring during treatment initiation
The class that started with a twice-daily Gila monster peptide is now expanding into oral small molecules and triple agonists and the dosing decision for any individual patient is going to depend more, not less, on how their biology responds
Some patients find that injecting in the evening before bedtime helps mask post-injection soreness with sleep, though individual preference varieschoose whatever time works best for your routine
Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S, et al
Around the same time, Eli Lilly filed an International Trade Commission complaint against 12 vendors selling imported tirzepatide